Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2234Neoplasms 2039Lung Neoplasms 1097Colorectal Neoplasms 1036Prostatic Neoplasms 894Carcinoma, Non-Small-Cell Lung 752Carcinoma, Hepatocellular 674Stomach Neoplasms 607Pancreatic Neoplasms 602Head and Neck Neoplasms 434Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 347Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 293Urinary Bladder Neoplasms 290Leukemia, Myeloid, Acute 278Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 252Disease 244Recurrence 225Glioma 218Carcinoma, Renal Cell 207

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × Breast Cancer Risk × Clear all
NCT05082740 2024-03-26

FH-Risk 2.0: Updating Breast Cancer Risk Estimates

University of Manchester

Completed
333 enrolled
Breast

Breast Cancer Risk

NCT00839696 2019-11-19

Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk

University of Wisconsin, Madison

Completed
270 enrolled
Breast

Breast Cancer Risk

Data powered by HemOnc (CC BY 4.0) Colophon âš¡